ResMed Inc (RMD) is a Healthcare · Medical Instruments & Supplies company listed on NYSE. Price $224.99 (-1.50%), Market cap $30.31B, P/E ratio 20.15, 52-week low–high $198.76 ~ $293.73.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and
Financial statements, price targets, institutional (13F) holdings and related news for ResMed Inc are updated in real time on BlackAll Trade.
ResMed Inc trades at $224.99 (-1.50%). Real-time quotes and charts are available on BlackAll Trade.
ResMed Inc has a market cap of about $30.31B. Its P/E ratio is 20.15.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and interna